These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 29158503

  • 1. Krüpple-like-factor 4 Attenuates Lung Fibrosis via Inhibiting Epithelial-mesenchymal Transition.
    Lin L, Han Q, Xiong Y, Li T, Liu Z, Xu H, Wu Y, Wang N, Liu X.
    Sci Rep; 2017 Nov 20; 7(1):15847. PubMed ID: 29158503
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.
    Han Q, Lin L, Zhao B, Wang N, Liu X.
    Biochem Biophys Res Commun; 2018 Jun 12; 500(4):839-845. PubMed ID: 29704504
    [Abstract] [Full Text] [Related]

  • 3. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis.
    Liu G, Wang Y, Yang L, Zou B, Gao S, Song Z, Lin Z.
    J Cell Mol Med; 2019 May 12; 23(5):3583-3596. PubMed ID: 30869194
    [Abstract] [Full Text] [Related]

  • 4. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
    Qian W, Cai X, Qian Q, Zhang W, Wang D.
    J Cell Mol Med; 2018 Sep 12; 22(9):4354-4365. PubMed ID: 29971947
    [Abstract] [Full Text] [Related]

  • 5. YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells.
    Zhang C, Zhu X, Hua Y, Zhao Q, Wang K, Zhen L, Wang G, Lü J, Luo A, Cho WC, Lin X, Yu Z.
    Respir Res; 2019 Nov 08; 20(1):249. PubMed ID: 31703732
    [Abstract] [Full Text] [Related]

  • 6. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
    Li LF, Kao KC, Liu YY, Lin CW, Chen NH, Lee CS, Wang CW, Yang CT.
    J Cell Mol Med; 2017 Nov 08; 21(11):2937-2949. PubMed ID: 28598023
    [Abstract] [Full Text] [Related]

  • 7. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R, Wang X, Zhao X, Song N, Zhu J, Wang J, Wang J, Xia C, Chen Y, Zhu D, Shen L.
    Sci Rep; 2016 Oct 24; 6():35696. PubMed ID: 27774992
    [Abstract] [Full Text] [Related]

  • 8. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
    Kanemaru R, Takahashi F, Kato M, Mitsuishi Y, Tajima K, Ihara H, Hidayat M, Wirawan A, Koinuma Y, Hayakawa D, Yagishita S, Ko R, Sato T, Harada N, Kodama Y, Nurwidya F, Sasaki S, Niwa SI, Takahashi K.
    Lung; 2018 Oct 24; 196(5):531-541. PubMed ID: 29926178
    [Abstract] [Full Text] [Related]

  • 9. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH.
    BMC Pharmacol Toxicol; 2018 Apr 02; 19(1):13. PubMed ID: 29609658
    [Abstract] [Full Text] [Related]

  • 10. Role of insulin like growth factor axis in the bleomycin induced lung injury in rats.
    Kotarkonda LK, Kulshrestha R, Ravi K.
    Exp Mol Pathol; 2017 Feb 02; 102(1):86-96. PubMed ID: 28077319
    [Abstract] [Full Text] [Related]

  • 11. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.
    Wang C, Song X, Li Y, Han F, Gao S, Wang X, Xie S, Lv C.
    PLoS One; 2013 Feb 02; 8(8):e70725. PubMed ID: 23967091
    [Abstract] [Full Text] [Related]

  • 12. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y, Wang T, Xia YF, Dai Y, Wei ZF.
    Acta Pharmacol Sin; 2016 Jun 02; 37(6):794-804. PubMed ID: 27133302
    [Abstract] [Full Text] [Related]

  • 13. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H, Lv Z, Liu S, Zhang L, Huang K, Gao S, Gan W, Liu X, Zhang S, Helian K, Li X, Zhou H, Yang C.
    J Pharm Pharmacol; 2020 Jan 02; 72(1):44-55. PubMed ID: 31659758
    [Abstract] [Full Text] [Related]

  • 14. Deficiency of CARMA3 attenuates the development of bleomycin induced pulmonary fibrosis.
    Wu Y, Qi Y, Qiu Z, Chen W.
    Biochem Biophys Res Commun; 2021 Dec 03; 581():81-88. PubMed ID: 34656852
    [Abstract] [Full Text] [Related]

  • 15. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice.
    Tanaka K, Tanaka Y, Namba T, Azuma A, Mizushima T.
    Biochem Pharmacol; 2010 Sep 15; 80(6):920-31. PubMed ID: 20513440
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
    Wang YC, Liu JS, Tang HK, Nie J, Zhu JX, Wen LL, Guo QL.
    Int J Mol Med; 2016 Oct 15; 38(4):1208-16. PubMed ID: 27513632
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.